PUBLIC RESEARCH DOSSIER
LLY · NYSE礼来
Manufacturing · Pharmaceutical Preparations完成交易日收盘US$1,409.38-0.11%行情日期 2026-11-03 · 非实时
礼来（Eli Lilly and Company / LLY）研发、制造并销售人用药品，并将其作为单一业务部门披露；产品包括Mounjaro和Zepbound，药物开发、制造产能、监管审批与支付准入共同影响可及性。
公开资料页汇总礼来（LLY）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。
股价走势
复权收盘价（美元）
2025-10-31 — 2026-11-03253 个交易日样本
LLYUS$1,409.38
查看图表数据
| 日期 | LLY |
|---|---|
| 2025-10-31 | 857.43 |
| 2025-11-03 | 890.89 |
| 2025-11-04 | 901.16 |
| 2025-11-05 | 919.99 |
| 2025-11-06 | 931.54 |
| 2025-11-07 | 918.56 |
| 2025-11-10 | 960.56 |
| 2025-11-11 | 982.4 |
| 2025-11-12 | 1,011.38 |
| 2025-11-13 | 1,016.44 |
| 2025-11-14 | 1,020.32 |
| 2025-11-17 | 1,016.76 |
| 2025-11-18 | 1,025.07 |
| 2025-11-19 | 1,044.52 |
| 2025-11-20 | 1,038.25 |
| 2025-11-21 | 1,054.58 |
| 2025-11-24 | 1,064.99 |
| 2025-11-25 | 1,104.57 |
| 2025-11-26 | 1,099 |
| 2025-11-28 | 1,070.27 |
| 2025-12-01 | 1,052.77 |
| 2025-12-02 | 1,041.06 |
| 2025-12-03 | 1,028.56 |
| 2025-12-04 | 1,009.58 |
| 2025-12-05 | 1,005.42 |
| 2025-12-08 | 992.77 |
| 2025-12-09 | 977.47 |
| 2025-12-10 | 988.84 |
| 2025-12-11 | 1,004.5 |
| 2025-12-12 | 1,022.54 |
| 2025-12-15 | 1,057.05 |
| 2025-12-16 | 1,049.19 |
| 2025-12-17 | 1,036.75 |
| 2025-12-18 | 1,051.77 |
| 2025-12-19 | 1,066.26 |
| 2025-12-22 | 1,071.27 |
| 2025-12-23 | 1,066.46 |
| 2025-12-24 | 1,071.77 |
| 2025-12-26 | 1,072.54 |
| 2025-12-29 | 1,073.51 |
| 2025-12-30 | 1,074.53 |
| 2025-12-31 | 1,069.48 |
| 2026-01-02 | 1,075.14 |
| 2026-01-05 | 1,036.47 |
| 2026-01-06 | 1,058.9 |
| 2026-01-07 | 1,102.73 |
| 2026-01-08 | 1,079.94 |
| 2026-01-09 | 1,058.42 |
| 2026-01-12 | 1,075.77 |
| 2026-01-13 | 1,071.98 |
| 2026-01-14 | 1,068.1 |
| 2026-01-15 | 1,027.98 |
| 2026-01-16 | 1,033.38 |
| 2026-01-20 | 1,036.26 |
| 2026-01-21 | 1,073.31 |
| 2026-01-22 | 1,082.12 |
| 2026-01-23 | 1,059.14 |
| 2026-01-26 | 1,057.61 |
| 2026-01-27 | 1,034.48 |
| 2026-01-28 | 1,018.85 |
| 2026-01-29 | 1,019.19 |
| 2026-01-30 | 1,032.14 |
| 2026-02-02 | 1,039.08 |
| 2026-02-03 | 998.61 |
| 2026-02-04 | 1,101.77 |
| 2026-02-05 | 1,015.9 |
| 2026-02-06 | 1,053.06 |
| 2026-02-09 | 1,039.62 |
| 2026-02-10 | 1,020.04 |
| 2026-02-11 | 1,010.3 |
| 2026-02-12 | 1,033.25 |
| 2026-02-13 | 1,036.69 |
| 2026-02-17 | 1,032.76 |
| 2026-02-18 | 1,017.31 |
| 2026-02-19 | 1,019.97 |
| 2026-02-20 | 1,006.31 |
| 2026-02-23 | 1,055.19 |
| 2026-02-24 | 1,038.84 |
| 2026-02-25 | 1,025.56 |
| 2026-02-26 | 1,018.77 |
| 2026-02-27 | 1,048.64 |
| 2026-03-02 | 1,014.73 |
| 2026-03-03 | 1,004.53 |
| 2026-03-04 | 1,000.38 |
| 2026-03-05 | 980.13 |
| 2026-03-06 | 987.18 |
| 2026-03-09 | 1,005.18 |
| 2026-03-10 | 998.17 |
| 2026-03-11 | 996.66 |
| 2026-03-12 | 974.14 |
| 2026-03-13 | 981.95 |
| 2026-03-16 | 985.97 |
| 2026-03-17 | 927.39 |
| 2026-03-18 | 915.13 |
| 2026-03-19 | 914.58 |
| 2026-03-20 | 903.82 |
| 2026-03-23 | 907.65 |
| 2026-03-24 | 900.15 |
| 2026-03-25 | 913.4 |
| 2026-03-26 | 894.15 |
| 2026-03-27 | 875.45 |
| 2026-03-30 | 883.81 |
| 2026-03-31 | 916.85 |
| 2026-04-01 | 951.48 |
| 2026-04-02 | 932.61 |
| 2026-04-06 | 924.11 |
| 2026-04-07 | 928.13 |
| 2026-04-08 | 950.27 |
| 2026-04-09 | 952.15 |
| 2026-04-10 | 936.48 |
| 2026-04-13 | 926.59 |
| 2026-04-14 | 919.57 |
| 2026-04-15 | 902.15 |
| 2026-04-16 | 901.12 |
| 2026-04-17 | 924.08 |
| 2026-04-20 | 916.97 |
| 2026-04-21 | 900.15 |
| 2026-04-22 | 918.55 |
| 2026-04-23 | 914.73 |
| 2026-04-24 | 881.15 |
| 2026-04-27 | 865.51 |
| 2026-04-28 | 871.22 |
| 2026-04-29 | 848.5 |
| 2026-04-30 | 931.63 |
| 2026-05-01 | 960.27 |
| 2026-05-04 | 964.85 |
| 2026-05-05 | 985.73 |
| 2026-05-06 | 983.91 |
| 2026-05-07 | 971.86 |
| 2026-05-08 | 945.43 |
| 2026-05-11 | 963.92 |
| 2026-05-12 | 986.72 |
| 2026-05-13 | 1,012.52 |
| 2026-05-14 | 1,003.5 |
| 2026-05-15 | 1,003.45 |
| 2026-05-18 | 986.64 |
| 2026-05-19 | 1,019.91 |
| 2026-05-20 | 1,017.38 |
| 2026-05-21 | 1,040.13 |
| 2026-05-22 | 1,063.44 |
| 2026-05-26 | 1,063.18 |
| 2026-05-27 | 1,081.33 |
| 2026-05-28 | 1,125.15 |
| 2026-05-29 | 1,103.38 |
| 2026-06-01 | 1,080.62 |
| 2026-06-02 | 1,062.59 |
| 2026-06-03 | 1,077.2 |
| 2026-06-04 | 1,123.62 |
| 2026-06-05 | 1,129.76 |
| 2026-06-08 | 1,147.47 |
| 2026-06-09 | 1,143 |
| 2026-06-10 | 1,134.71 |
| 2026-06-11 | 1,159.25 |
| 2026-06-12 | 1,131.34 |
| 2026-06-15 | 1,127.7 |
| 2026-06-16 | 1,120.86 |
| 2026-06-17 | 1,110.37 |
| 2026-06-18 | 1,096.96 |
| 2026-06-22 | 1,100.47 |
| 2026-06-23 | 1,105.46 |
| 2026-06-24 | 1,115.62 |
| 2026-06-25 | 1,126.04 |
| 2026-06-26 | 1,206.35 |
| 2026-06-29 | 1,228.13 |
| 2026-06-30 | 1,197.67 |
| 2026-07-01 | 1,190 |
| 2026-07-02 | 1,212.13 |
| 2026-07-06 | 1,198.3 |
| 2026-07-07 | 1,233.75 |
| 2026-07-08 | 1,214.05 |
| 2026-07-09 | 1,215.17 |
| 2026-07-10 | 1,186.84 |
| 2026-07-13 | 1,180.14 |
| 2026-07-14 | 1,150.85 |
| 2026-07-15 | 1,154.94 |
| 2026-07-16 | 1,167.46 |
| 2026-07-17 | 1,177.38 |
| 2026-07-20 | 1,145.22 |
| 2026-07-21 | 1,173.69 |
| 2026-07-22 | 1,161.31 |
| 2026-07-23 | 1,184.13 |
| 2026-07-24 | 1,194.28 |
| 2026-07-27 | 1,195.78 |
| 2026-07-28 | 1,218.87 |
| 2026-07-29 | 1,208.25 |
| 2026-07-30 | 1,153.28 |
| 2026-07-31 | 1,147.16 |
| 2026-08-03 | 1,119.72 |
| 2026-08-04 | 1,114.05 |
| 2026-08-05 | 1,168.15 |
| 2026-08-06 | 1,190.2 |
| 2026-08-07 | 1,183.97 |
| 2026-08-10 | 1,230.14 |
| 2026-08-11 | 1,213.24 |
| 2026-08-12 | 1,218.49 |
| 2026-08-13 | 1,207.23 |
| 2026-08-14 | 1,180.16 |
| 2026-08-17 | 1,183.16 |
| 2026-08-18 | 1,225.73 |
| 2026-08-19 | 1,280.34 |
| 2026-08-20 | 1,244.4 |
| 2026-08-21 | 1,255.4 |
| 2026-08-24 | 1,246.93 |
| 2026-08-25 | 1,233.66 |
| 2026-08-26 | 1,189.41 |
| 2026-08-27 | 1,176.1 |
| 2026-08-28 | 1,174.61 |
| 2026-08-31 | 1,156.73 |
| 2026-09-01 | 1,160 |
| 2026-09-02 | 1,160.08 |
| 2026-09-03 | 1,159.6 |
| 2026-09-04 | 1,149.36 |
| 2026-09-08 | 1,123.91 |
| 2026-09-09 | 1,124.21 |
| 2026-09-10 | 1,123 |
| 2026-09-11 | 1,115.7 |
| 2026-09-14 | 1,138.28 |
| 2026-09-15 | 1,136.11 |
| 2026-09-16 | 1,137.82 |
| 2026-09-17 | 1,152.44 |
| 2026-09-18 | 1,152.93 |
| 2026-09-21 | 1,164.89 |
| 2026-09-22 | 1,170.14 |
| 2026-09-23 | 1,150.99 |
| 2026-09-24 | 1,181.89 |
| 2026-09-25 | 1,183.46 |
| 2026-09-28 | 1,184.78 |
| 2026-09-29 | 1,184.63 |
| 2026-09-30 | 1,157.08 |
| 2026-10-01 | 1,149.85 |
| 2026-10-02 | 1,142.85 |
| 2026-10-05 | 1,143.12 |
| 2026-10-06 | 1,157.49 |
| 2026-10-07 | 1,188.72 |
| 2026-10-08 | 1,169.6 |
| 2026-10-09 | 1,179.27 |
| 2026-10-12 | 1,182.62 |
| 2026-10-13 | 1,166.51 |
| 2026-10-14 | 1,208.74 |
| 2026-10-15 | 1,251.61 |
| 2026-10-16 | 1,257.03 |
| 2026-10-19 | 1,240.34 |
| 2026-10-20 | 1,283.66 |
| 2026-10-21 | 1,270.75 |
| 2026-10-22 | 1,306.69 |
| 2026-10-23 | 1,273.46 |
| 2026-10-26 | 1,279.14 |
| 2026-10-27 | 1,281.91 |
| 2026-10-28 | 1,288.3 |
| 2026-10-29 | 1,373.7 |
| 2026-10-30 | 1,417.54 |
| 2026-11-02 | 1,410.99 |
| 2026-11-03 | 1,409.38 |
1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。
使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。
01 · MARKET FRAME
行情、估值与风险
基于已完成交易日和已发布财务资料
区间涨跌幅
区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。
02 · FINANCIAL TRACE
财务摘要
公开页仅显示最近3个已校验报告期
年度财务走势
百万美元 · 年度报告期
营收65,179百万美元
| 指标 | 2026-08-03 | 2026-06-30 | 2025-12-31 | 2025-08-04 | 2025-06-30 | 2024-12-31 | 2024-08-05 | 2024-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| 营收 | — | — | 65,179 | — | — | 45,043 | — | — | 34,124 |
| 净利润 | — | — | 20,640 | — | — | 10,590 | — | — | 5,240 |
| 自由现金流 | — | — | — | — | — | — | — | — | — |
| 股份数 | 941.4 | — | — | 946.5 | — | — | 950.4 | — | — |
| 债务 | — | — | — | — | — | — | — | — | — |
| 总资产 | — | 142,283 | — | — | 100,922.6 | — | — | 71,874.8 | — |
报告营收口径
金额及股份数均以百万为单位。缺失或待核验数据不按零处理。
03 · PEER SET
同业对比
同一细分行业中市值最接近的公司
| 公司 | 市值 | 近250日涨跌幅 | 市盈率 | 距52周高点 | 波动率 |
|---|---|---|---|---|---|
| JNJ强生 | US$640.8B | +45.7% | 30.5× | -4.4% | +20.7% |
| ABBV艾伯维 | US$505.4B | +35.6% | 80.1× | -3% | +25.4% |
| MRK默沙东 | US$356.9B | +76.6% | 112.5× | -7.5% | +30.1% |
| NVS诺华制药 | US$303.9B | +31.3% | — | -2.7% | +26.7% |
同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。